LXRβ/NF-κB轴重新编程CAR-T细胞以抵御瘤微环境中的耗尽
Minji Lim1,2, Sang-Eun Jung1,2, Choong-Hyun Koh1,3
1Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Oncoimmunology
|January 7, 2026
概括
肝脏X受体β (LXRβ) 调节瘤中的CAR-T细胞功能. 准LXRβ和NF-κB信号增强了CAR-T细胞的抗瘤活性,并减少了疲劳.
科学领域:
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 肝脏X受体β (LXRβ) 影响脂质代谢和免疫反应.
- 在瘤透T细胞,特别是CAR-T细胞中LXRβ的作用尚不清楚.
- 瘤微环境 (TME) 中LXRβ和NF-κB信号之间的相互作用需要进一步阐明.
研究的目的:
- 研究LXRβ在CAR-T细胞分化,新陈代谢和固体瘤中的功能中的作用.
- 在CAR-T细胞中探索LXRβ和NF-κB信号传递之间的机制联系.
- 评估向LXRβ-NF-κB轴以增强CAR-T细胞治疗的治疗潜力.
主要方法:
- 对LXRβ对CAR-T细胞转录和表型特征的影响分析.
- 在CAR-T细胞中对NF-κB成分 (例如RelB) 的基因操纵.
- 在体内研究评估联合LXRβ和RelB向的抗瘤疗效.
主要成果:
- 调节LXRβ过度表达的CAR-T细胞干细胞样种群,增殖和细胞因子产生.
- 破坏非正规NF-κB信号传递 (RelB) 改善了CAR-T细胞细胞毒性,并减少了疲劳标记.
- 结合LXRβ和RelB向显示了新陈代谢适应性增加/协同改善,减少疲劳,并增强了体内抗瘤活性.
结论:
- 在TME中,LXRβ是CAR-T细胞命运和功能的关键调节者.
- LXRβ-NF-κB轴代表了一种影响CAR-T细胞性能的新型调节途径.
- 针对这种途径有望改善针对固体瘤的CAR-T细胞疗法.
相关概念视频
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
Co-activators and Co-repressors
8.4K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.4K
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K


